nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP2C19—coronary artery disease	0.149	1	CbGaD
Fluvoxamine—CYP2B6—Clopidogrel—coronary artery disease	0.0164	0.0287	CbGbCtD
Fluvoxamine—CYP3A7—Eplerenone—coronary artery disease	0.016	0.028	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.016	0.028	CbGbCtD
Fluvoxamine—ABCB1—Ticagrelor—coronary artery disease	0.0136	0.0238	CbGbCtD
Fluvoxamine—CYP3A5—Clopidogrel—coronary artery disease	0.0129	0.0226	CbGbCtD
Fluvoxamine—CYP2C9—Fenofibrate—coronary artery disease	0.0125	0.0218	CbGbCtD
Fluvoxamine—CYP2C19—Gemfibrozil—coronary artery disease	0.012	0.021	CbGbCtD
Fluvoxamine—CYP3A5—Eplerenone—coronary artery disease	0.012	0.021	CbGbCtD
Fluvoxamine—CYP1A2—Gemfibrozil—coronary artery disease	0.0111	0.0194	CbGbCtD
Fluvoxamine—CYP2C19—Clopidogrel—coronary artery disease	0.0104	0.0182	CbGbCtD
Fluvoxamine—CYP3A7—Simvastatin—coronary artery disease	0.0103	0.018	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0103	0.018	CbGbCtD
Fluvoxamine—CYP3A7—Lovastatin—coronary artery disease	0.0101	0.0176	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0101	0.0176	CbGbCtD
Fluvoxamine—CYP2C9—Gemfibrozil—coronary artery disease	0.01	0.0175	CbGbCtD
Fluvoxamine—CYP2B6—Simvastatin—coronary artery disease	0.00983	0.0172	CbGbCtD
Fluvoxamine—CYP1A2—Clopidogrel—coronary artery disease	0.00963	0.0168	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00921	0.0161	CbGbCtD
Fluvoxamine—CYP3A7—Atorvastatin—coronary artery disease	0.00921	0.0161	CbGbCtD
Fluvoxamine—CYP2C19—Telmisartan—coronary artery disease	0.00912	0.0159	CbGbCtD
Fluvoxamine—CYP2B6—Atorvastatin—coronary artery disease	0.00877	0.0153	CbGbCtD
Fluvoxamine—CYP2C9—Clopidogrel—coronary artery disease	0.00867	0.0151	CbGbCtD
Fluvoxamine—ABCB1—Perindopril—coronary artery disease	0.00842	0.0147	CbGbCtD
Fluvoxamine—ABCB1—Clopidogrel—coronary artery disease	0.00842	0.0147	CbGbCtD
Fluvoxamine—CYP3A5—Rosuvastatin—coronary artery disease	0.00833	0.0145	CbGbCtD
Fluvoxamine—CYP3A4—Ticagrelor—coronary artery disease	0.00816	0.0142	CbGbCtD
Fluvoxamine—CYP3A5—Simvastatin—coronary artery disease	0.00775	0.0135	CbGbCtD
Fluvoxamine—CYP3A5—Lovastatin—coronary artery disease	0.00758	0.0132	CbGbCtD
Fluvoxamine—CYP3A5—Pravastatin—coronary artery disease	0.00758	0.0132	CbGbCtD
Fluvoxamine—CYP2C9—Pitavastatin—coronary artery disease	0.00758	0.0132	CbGbCtD
Fluvoxamine—CYP2C9—Valsartan—coronary artery disease	0.00737	0.0129	CbGbCtD
Fluvoxamine—ABCB1—Pitavastatin—coronary artery disease	0.00736	0.0128	CbGbCtD
Fluvoxamine—ABCB1—Telmisartan—coronary artery disease	0.00736	0.0128	CbGbCtD
Fluvoxamine—CYP2C19—Timolol—coronary artery disease	0.00735	0.0128	CbGbCtD
Fluvoxamine—CYP3A4—Fenofibrate—coronary artery disease	0.00728	0.0127	CbGbCtD
Fluvoxamine—ABCB1—Enalapril—coronary artery disease	0.00697	0.0122	CbGbCtD
Fluvoxamine—ABCB1—Lisinopril—coronary artery disease	0.00697	0.0122	CbGbCtD
Fluvoxamine—CYP3A5—Atorvastatin—coronary artery disease	0.00691	0.0121	CbGbCtD
Fluvoxamine—CYP2C19—Rosuvastatin—coronary artery disease	0.00672	0.0117	CbGbCtD
Fluvoxamine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00655	0.0114	CbGbCtD
Fluvoxamine—CYP3A5—Losartan—coronary artery disease	0.00632	0.011	CbGbCtD
Fluvoxamine—CYP2C19—Simvastatin—coronary artery disease	0.00625	0.0109	CbGbCtD
Fluvoxamine—CYP2C19—Lovastatin—coronary artery disease	0.00612	0.0107	CbGbCtD
Fluvoxamine—CYP2D6—Niacin—coronary artery disease	0.00601	0.0105	CbGbCtD
Fluvoxamine—ABCB1—Timolol—coronary artery disease	0.00593	0.0104	CbGbCtD
Fluvoxamine—CYP3A4—Gemfibrozil—coronary artery disease	0.00582	0.0102	CbGbCtD
Fluvoxamine—CYP2C9—Rosuvastatin—coronary artery disease	0.00559	0.00975	CbGbCtD
Fluvoxamine—CYP2D6—Timolol—coronary artery disease	0.00559	0.00975	CbGbCtD
Fluvoxamine—CYP2C19—Atorvastatin—coronary artery disease	0.00557	0.00972	CbGbCtD
Fluvoxamine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00545	0.00951	CbGbCtD
Fluvoxamine—ABCB1—Ezetimibe—coronary artery disease	0.00542	0.00947	CbGbCtD
Fluvoxamine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00529	0.00923	CbGbCtD
Fluvoxamine—ABCB1—Captopril—coronary artery disease	0.00522	0.00911	CbGbCtD
Fluvoxamine—CYP2C9—Simvastatin—coronary artery disease	0.0052	0.00907	CbGbCtD
Fluvoxamine—CYP2C19—Losartan—coronary artery disease	0.00509	0.00889	CbGbCtD
Fluvoxamine—CYP2C9—Lovastatin—coronary artery disease	0.00508	0.00887	CbGbCtD
Fluvoxamine—CYP2C9—Pravastatin—coronary artery disease	0.00508	0.00887	CbGbCtD
Fluvoxamine—CYP3A4—Clopidogrel—coronary artery disease	0.00504	0.0088	CbGbCtD
Fluvoxamine—ABCB1—Simvastatin—coronary artery disease	0.00504	0.0088	CbGbCtD
Fluvoxamine—ABCB1—Pravastatin—coronary artery disease	0.00493	0.00861	CbGbCtD
Fluvoxamine—ABCB1—Lovastatin—coronary artery disease	0.00493	0.00861	CbGbCtD
Fluvoxamine—CYP2D6—Captopril—coronary artery disease	0.00492	0.00859	CbGbCtD
Fluvoxamine—CYP2D6—Simvastatin—coronary artery disease	0.00475	0.00829	CbGbCtD
Fluvoxamine—CYP1A2—Losartan—coronary artery disease	0.0047	0.0082	CbGbCtD
Fluvoxamine—CYP3A4—Eplerenone—coronary artery disease	0.00469	0.00818	CbGbCtD
Fluvoxamine—CYP2D6—Lovastatin—coronary artery disease	0.00465	0.00812	CbGbCtD
Fluvoxamine—CYP2D6—Pravastatin—coronary artery disease	0.00465	0.00812	CbGbCtD
Fluvoxamine—CYP2C9—Atorvastatin—coronary artery disease	0.00463	0.00808	CbGbCtD
Fluvoxamine—ABCB1—Atorvastatin—coronary artery disease	0.00449	0.00784	CbGbCtD
Fluvoxamine—CYP2C9—Losartan—coronary artery disease	0.00424	0.00739	CbGbCtD
Fluvoxamine—CYP2D6—Atorvastatin—coronary artery disease	0.00423	0.00739	CbGbCtD
Fluvoxamine—CYP3A4—Enalapril—coronary artery disease	0.00418	0.00729	CbGbCtD
Fluvoxamine—ABCB1—Losartan—coronary artery disease	0.00411	0.00717	CbGbCtD
Fluvoxamine—CYP3A4—Ezetimibe—coronary artery disease	0.00325	0.00567	CbGbCtD
Fluvoxamine—CYP3A4—Rosuvastatin—coronary artery disease	0.00325	0.00567	CbGbCtD
Fluvoxamine—CYP3A4—Simvastatin—coronary artery disease	0.00302	0.00527	CbGbCtD
Fluvoxamine—CYP3A4—Pravastatin—coronary artery disease	0.00296	0.00516	CbGbCtD
Fluvoxamine—CYP3A4—Lovastatin—coronary artery disease	0.00296	0.00516	CbGbCtD
Fluvoxamine—CYP3A4—Atorvastatin—coronary artery disease	0.00269	0.0047	CbGbCtD
Fluvoxamine—CYP3A4—Losartan—coronary artery disease	0.00246	0.0043	CbGbCtD
Fluvoxamine—CYP2C9—cardial valve—coronary artery disease	0.000751	0.409	CbGeAlD
Fluvoxamine—SIGMAR1—cardiac ventricle—coronary artery disease	9.77e-05	0.0532	CbGeAlD
Fluvoxamine—SIGMAR1—myocardium—coronary artery disease	9.19e-05	0.0501	CbGeAlD
Fluvoxamine—CYP1A1—cardiac ventricle—coronary artery disease	6.57e-05	0.0358	CbGeAlD
Fluvoxamine—SIGMAR1—heart—coronary artery disease	6.41e-05	0.035	CbGeAlD
Fluvoxamine—SIGMAR1—cardiac atrium—coronary artery disease	5.49e-05	0.0299	CbGeAlD
Fluvoxamine—SLC6A4—blood—coronary artery disease	4.82e-05	0.0263	CbGeAlD
Fluvoxamine—SIGMAR1—blood—coronary artery disease	4.79e-05	0.0261	CbGeAlD
Fluvoxamine—CYP1A1—heart—coronary artery disease	4.31e-05	0.0235	CbGeAlD
Fluvoxamine—CYP2B6—heart—coronary artery disease	4.19e-05	0.0228	CbGeAlD
Fluvoxamine—CYP2C9—heart—coronary artery disease	4.15e-05	0.0226	CbGeAlD
Fluvoxamine—CYP2C19—blood—coronary artery disease	3.99e-05	0.0218	CbGeAlD
Fluvoxamine—CYP2B6—cardiovascular system—coronary artery disease	3.95e-05	0.0215	CbGeAlD
Fluvoxamine—CYP2C9—cardiovascular system—coronary artery disease	3.91e-05	0.0213	CbGeAlD
Fluvoxamine—CYP2E1—cardiovascular system—coronary artery disease	3.71e-05	0.0202	CbGeAlD
Fluvoxamine—CYP1A1—cardiac atrium—coronary artery disease	3.69e-05	0.0201	CbGeAlD
Fluvoxamine—Discomfort—Timolol—coronary artery disease	3.31e-05	0.00016	CcSEcCtD
Fluvoxamine—Asthenia—Niacin—coronary artery disease	3.31e-05	0.000159	CcSEcCtD
Fluvoxamine—Fatigue—Losartan—coronary artery disease	3.3e-05	0.000159	CcSEcCtD
Fluvoxamine—Headache—Ezetimibe—coronary artery disease	3.3e-05	0.000159	CcSEcCtD
Fluvoxamine—Malaise—Lisinopril—coronary artery disease	3.29e-05	0.000159	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Ramipril—coronary artery disease	3.29e-05	0.000158	CcSEcCtD
Fluvoxamine—Oedema—Ramipril—coronary artery disease	3.29e-05	0.000158	CcSEcCtD
Fluvoxamine—Vertigo—Lisinopril—coronary artery disease	3.28e-05	0.000158	CcSEcCtD
Fluvoxamine—Dry mouth—Timolol—coronary artery disease	3.28e-05	0.000158	CcSEcCtD
Fluvoxamine—Pain—Losartan—coronary artery disease	3.28e-05	0.000158	CcSEcCtD
Fluvoxamine—Constipation—Losartan—coronary artery disease	3.28e-05	0.000158	CcSEcCtD
Fluvoxamine—Syncope—Lisinopril—coronary artery disease	3.28e-05	0.000158	CcSEcCtD
Fluvoxamine—Vomiting—Eplerenone—coronary artery disease	3.27e-05	0.000158	CcSEcCtD
Fluvoxamine—Feeling abnormal—Furosemide—coronary artery disease	3.27e-05	0.000158	CcSEcCtD
Fluvoxamine—Leukopenia—Lisinopril—coronary artery disease	3.27e-05	0.000158	CcSEcCtD
Fluvoxamine—Nausea—Fenofibrate—coronary artery disease	3.26e-05	0.000157	CcSEcCtD
Fluvoxamine—CYP1A2—blood—coronary artery disease	3.26e-05	0.0178	CbGeAlD
Fluvoxamine—Pruritus—Niacin—coronary artery disease	3.26e-05	0.000157	CcSEcCtD
Fluvoxamine—Asthenia—Pravastatin—coronary artery disease	3.26e-05	0.000157	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Furosemide—coronary artery disease	3.25e-05	0.000157	CcSEcCtD
Fluvoxamine—Rash—Eplerenone—coronary artery disease	3.25e-05	0.000156	CcSEcCtD
Fluvoxamine—Urticaria—Perindopril—coronary artery disease	3.25e-05	0.000156	CcSEcCtD
Fluvoxamine—Hypersensitivity—Trandolapril—coronary artery disease	3.25e-05	0.000156	CcSEcCtD
Fluvoxamine—Dermatitis—Eplerenone—coronary artery disease	3.24e-05	0.000156	CcSEcCtD
Fluvoxamine—Diarrhoea—Valsartan—coronary artery disease	3.24e-05	0.000156	CcSEcCtD
Fluvoxamine—Confusional state—Timolol—coronary artery disease	3.24e-05	0.000156	CcSEcCtD
Fluvoxamine—Shock—Ramipril—coronary artery disease	3.23e-05	0.000156	CcSEcCtD
Fluvoxamine—Hypersensitivity—Enalapril—coronary artery disease	3.23e-05	0.000156	CcSEcCtD
Fluvoxamine—Abdominal pain—Perindopril—coronary artery disease	3.23e-05	0.000156	CcSEcCtD
Fluvoxamine—Body temperature increased—Perindopril—coronary artery disease	3.23e-05	0.000156	CcSEcCtD
Fluvoxamine—Palpitations—Lisinopril—coronary artery disease	3.23e-05	0.000156	CcSEcCtD
Fluvoxamine—Diarrhoea—Olmesartan—coronary artery disease	3.23e-05	0.000156	CcSEcCtD
Fluvoxamine—Headache—Eplerenone—coronary artery disease	3.23e-05	0.000155	CcSEcCtD
Fluvoxamine—Nervous system disorder—Ramipril—coronary artery disease	3.22e-05	0.000155	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Ramipril—coronary artery disease	3.22e-05	0.000155	CcSEcCtD
Fluvoxamine—CYP1A1—blood—coronary artery disease	3.22e-05	0.0175	CbGeAlD
Fluvoxamine—Oedema—Timolol—coronary artery disease	3.21e-05	0.000155	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Timolol—coronary artery disease	3.21e-05	0.000155	CcSEcCtD
Fluvoxamine—Pruritus—Pravastatin—coronary artery disease	3.21e-05	0.000155	CcSEcCtD
Fluvoxamine—Loss of consciousness—Lisinopril—coronary artery disease	3.21e-05	0.000155	CcSEcCtD
Fluvoxamine—Nausea—Clopidogrel—coronary artery disease	3.21e-05	0.000155	CcSEcCtD
Fluvoxamine—Tachycardia—Ramipril—coronary artery disease	3.21e-05	0.000155	CcSEcCtD
Fluvoxamine—Infection—Timolol—coronary artery disease	3.19e-05	0.000154	CcSEcCtD
Fluvoxamine—Vomiting—Simvastatin—coronary artery disease	3.19e-05	0.000154	CcSEcCtD
Fluvoxamine—Hypersensitivity—Telmisartan—coronary artery disease	3.19e-05	0.000154	CcSEcCtD
Fluvoxamine—Cough—Lisinopril—coronary artery disease	3.19e-05	0.000154	CcSEcCtD
Fluvoxamine—Nausea—Lovastatin—coronary artery disease	3.19e-05	0.000154	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Ramipril—coronary artery disease	3.18e-05	0.000153	CcSEcCtD
Fluvoxamine—Rash—Simvastatin—coronary artery disease	3.16e-05	0.000152	CcSEcCtD
Fluvoxamine—Dermatitis—Simvastatin—coronary artery disease	3.16e-05	0.000152	CcSEcCtD
Fluvoxamine—Asthenia—Trandolapril—coronary artery disease	3.16e-05	0.000152	CcSEcCtD
Fluvoxamine—Shock—Timolol—coronary artery disease	3.16e-05	0.000152	CcSEcCtD
Fluvoxamine—Feeling abnormal—Losartan—coronary artery disease	3.16e-05	0.000152	CcSEcCtD
Fluvoxamine—Urticaria—Furosemide—coronary artery disease	3.16e-05	0.000152	CcSEcCtD
Fluvoxamine—Diarrhoea—Niacin—coronary artery disease	3.15e-05	0.000152	CcSEcCtD
Fluvoxamine—Nervous system disorder—Timolol—coronary artery disease	3.15e-05	0.000152	CcSEcCtD
Fluvoxamine—Asthenia—Enalapril—coronary artery disease	3.15e-05	0.000152	CcSEcCtD
Fluvoxamine—CYP3A5—blood—coronary artery disease	3.15e-05	0.0171	CbGeAlD
Fluvoxamine—Headache—Simvastatin—coronary artery disease	3.14e-05	0.000151	CcSEcCtD
Fluvoxamine—Body temperature increased—Furosemide—coronary artery disease	3.14e-05	0.000151	CcSEcCtD
Fluvoxamine—Abdominal pain—Furosemide—coronary artery disease	3.14e-05	0.000151	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Losartan—coronary artery disease	3.13e-05	0.000151	CcSEcCtD
Fluvoxamine—Dizziness—Valsartan—coronary artery disease	3.13e-05	0.000151	CcSEcCtD
Fluvoxamine—Anorexia—Ramipril—coronary artery disease	3.13e-05	0.000151	CcSEcCtD
Fluvoxamine—CYP2B6—blood—coronary artery disease	3.13e-05	0.017	CbGeAlD
Fluvoxamine—Nausea—Ezetimibe—coronary artery disease	3.13e-05	0.000151	CcSEcCtD
Fluvoxamine—Dizziness—Olmesartan—coronary artery disease	3.12e-05	0.00015	CcSEcCtD
Fluvoxamine—Pruritus—Trandolapril—coronary artery disease	3.12e-05	0.00015	CcSEcCtD
Fluvoxamine—Myalgia—Lisinopril—coronary artery disease	3.11e-05	0.00015	CcSEcCtD
Fluvoxamine—Chest pain—Lisinopril—coronary artery disease	3.11e-05	0.00015	CcSEcCtD
Fluvoxamine—Arthralgia—Lisinopril—coronary artery disease	3.11e-05	0.00015	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Timolol—coronary artery disease	3.11e-05	0.00015	CcSEcCtD
Fluvoxamine—Asthenia—Telmisartan—coronary artery disease	3.11e-05	0.00015	CcSEcCtD
Fluvoxamine—Pruritus—Enalapril—coronary artery disease	3.1e-05	0.00015	CcSEcCtD
Fluvoxamine—Diarrhoea—Pravastatin—coronary artery disease	3.1e-05	0.00015	CcSEcCtD
Fluvoxamine—Anxiety—Lisinopril—coronary artery disease	3.1e-05	0.000149	CcSEcCtD
Fluvoxamine—CYP2C9—blood—coronary artery disease	3.1e-05	0.0169	CbGeAlD
Fluvoxamine—Discomfort—Lisinopril—coronary artery disease	3.07e-05	0.000148	CcSEcCtD
Fluvoxamine—Hypotension—Ramipril—coronary artery disease	3.07e-05	0.000148	CcSEcCtD
Fluvoxamine—Anorexia—Timolol—coronary artery disease	3.06e-05	0.000148	CcSEcCtD
Fluvoxamine—Pruritus—Telmisartan—coronary artery disease	3.06e-05	0.000148	CcSEcCtD
Fluvoxamine—Nausea—Eplerenone—coronary artery disease	3.06e-05	0.000147	CcSEcCtD
Fluvoxamine—Dizziness—Niacin—coronary artery disease	3.05e-05	0.000147	CcSEcCtD
Fluvoxamine—Urticaria—Losartan—coronary artery disease	3.05e-05	0.000147	CcSEcCtD
Fluvoxamine—Dry mouth—Lisinopril—coronary artery disease	3.04e-05	0.000147	CcSEcCtD
Fluvoxamine—Body temperature increased—Losartan—coronary artery disease	3.03e-05	0.000146	CcSEcCtD
Fluvoxamine—Abdominal pain—Losartan—coronary artery disease	3.03e-05	0.000146	CcSEcCtD
Fluvoxamine—Asthenia—Captopril—coronary artery disease	3.02e-05	0.000146	CcSEcCtD
Fluvoxamine—Diarrhoea—Trandolapril—coronary artery disease	3.01e-05	0.000145	CcSEcCtD
Fluvoxamine—Vomiting—Valsartan—coronary artery disease	3.01e-05	0.000145	CcSEcCtD
Fluvoxamine—Confusional state—Lisinopril—coronary artery disease	3.01e-05	0.000145	CcSEcCtD
Fluvoxamine—Diarrhoea—Enalapril—coronary artery disease	3e-05	0.000145	CcSEcCtD
Fluvoxamine—Hypotension—Timolol—coronary artery disease	3e-05	0.000145	CcSEcCtD
Fluvoxamine—Dizziness—Pravastatin—coronary artery disease	3e-05	0.000145	CcSEcCtD
Fluvoxamine—Vomiting—Olmesartan—coronary artery disease	3e-05	0.000145	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.99e-05	0.000144	CcSEcCtD
Fluvoxamine—Rash—Valsartan—coronary artery disease	2.99e-05	0.000144	CcSEcCtD
Fluvoxamine—Dermatitis—Valsartan—coronary artery disease	2.99e-05	0.000144	CcSEcCtD
Fluvoxamine—Nausea—Simvastatin—coronary artery disease	2.98e-05	0.000144	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Lisinopril—coronary artery disease	2.98e-05	0.000144	CcSEcCtD
Fluvoxamine—Oedema—Lisinopril—coronary artery disease	2.98e-05	0.000144	CcSEcCtD
Fluvoxamine—Pruritus—Captopril—coronary artery disease	2.98e-05	0.000143	CcSEcCtD
Fluvoxamine—Rash—Olmesartan—coronary artery disease	2.97e-05	0.000143	CcSEcCtD
Fluvoxamine—Insomnia—Ramipril—coronary artery disease	2.97e-05	0.000143	CcSEcCtD
Fluvoxamine—Dermatitis—Olmesartan—coronary artery disease	2.97e-05	0.000143	CcSEcCtD
Fluvoxamine—Headache—Valsartan—coronary artery disease	2.97e-05	0.000143	CcSEcCtD
Fluvoxamine—Diarrhoea—Telmisartan—coronary artery disease	2.96e-05	0.000143	CcSEcCtD
Fluvoxamine—Infection—Lisinopril—coronary artery disease	2.96e-05	0.000143	CcSEcCtD
Fluvoxamine—Headache—Olmesartan—coronary artery disease	2.95e-05	0.000142	CcSEcCtD
Fluvoxamine—Paraesthesia—Ramipril—coronary artery disease	2.95e-05	0.000142	CcSEcCtD
Fluvoxamine—CYP2E1—blood—coronary artery disease	2.93e-05	0.016	CbGeAlD
Fluvoxamine—Shock—Lisinopril—coronary artery disease	2.93e-05	0.000141	CcSEcCtD
Fluvoxamine—Asthenia—Perindopril—coronary artery disease	2.93e-05	0.000141	CcSEcCtD
Fluvoxamine—Dyspnoea—Ramipril—coronary artery disease	2.93e-05	0.000141	CcSEcCtD
Fluvoxamine—Vomiting—Niacin—coronary artery disease	2.93e-05	0.000141	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Timolol—coronary artery disease	2.93e-05	0.000141	CcSEcCtD
Fluvoxamine—Hypersensitivity—Furosemide—coronary artery disease	2.93e-05	0.000141	CcSEcCtD
Fluvoxamine—Somnolence—Ramipril—coronary artery disease	2.92e-05	0.000141	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Lisinopril—coronary artery disease	2.92e-05	0.000141	CcSEcCtD
Fluvoxamine—Dizziness—Trandolapril—coronary artery disease	2.91e-05	0.00014	CcSEcCtD
Fluvoxamine—Tachycardia—Lisinopril—coronary artery disease	2.91e-05	0.00014	CcSEcCtD
Fluvoxamine—Insomnia—Timolol—coronary artery disease	2.91e-05	0.00014	CcSEcCtD
Fluvoxamine—Rash—Niacin—coronary artery disease	2.91e-05	0.00014	CcSEcCtD
Fluvoxamine—Dermatitis—Niacin—coronary artery disease	2.9e-05	0.00014	CcSEcCtD
Fluvoxamine—Dizziness—Enalapril—coronary artery disease	2.9e-05	0.00014	CcSEcCtD
Fluvoxamine—Dyspepsia—Ramipril—coronary artery disease	2.89e-05	0.000139	CcSEcCtD
Fluvoxamine—Pruritus—Perindopril—coronary artery disease	2.89e-05	0.000139	CcSEcCtD
Fluvoxamine—Headache—Niacin—coronary artery disease	2.89e-05	0.000139	CcSEcCtD
Fluvoxamine—Paraesthesia—Timolol—coronary artery disease	2.89e-05	0.000139	CcSEcCtD
Fluvoxamine—Vomiting—Pravastatin—coronary artery disease	2.88e-05	0.000139	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Lisinopril—coronary artery disease	2.88e-05	0.000139	CcSEcCtD
Fluvoxamine—Diarrhoea—Captopril—coronary artery disease	2.88e-05	0.000139	CcSEcCtD
Fluvoxamine—Dyspnoea—Timolol—coronary artery disease	2.86e-05	0.000138	CcSEcCtD
Fluvoxamine—Dizziness—Telmisartan—coronary artery disease	2.86e-05	0.000138	CcSEcCtD
Fluvoxamine—Rash—Pravastatin—coronary artery disease	2.86e-05	0.000138	CcSEcCtD
Fluvoxamine—Dermatitis—Pravastatin—coronary artery disease	2.86e-05	0.000138	CcSEcCtD
Fluvoxamine—Decreased appetite—Ramipril—coronary artery disease	2.86e-05	0.000138	CcSEcCtD
Fluvoxamine—Somnolence—Timolol—coronary artery disease	2.86e-05	0.000138	CcSEcCtD
Fluvoxamine—Asthenia—Furosemide—coronary artery disease	2.85e-05	0.000137	CcSEcCtD
Fluvoxamine—Headache—Pravastatin—coronary artery disease	2.84e-05	0.000137	CcSEcCtD
Fluvoxamine—Anorexia—Lisinopril—coronary artery disease	2.84e-05	0.000137	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Ramipril—coronary artery disease	2.84e-05	0.000137	CcSEcCtD
Fluvoxamine—Fatigue—Ramipril—coronary artery disease	2.83e-05	0.000137	CcSEcCtD
Fluvoxamine—Dyspepsia—Timolol—coronary artery disease	2.83e-05	0.000136	CcSEcCtD
Fluvoxamine—Hypersensitivity—Losartan—coronary artery disease	2.82e-05	0.000136	CcSEcCtD
Fluvoxamine—Nausea—Valsartan—coronary artery disease	2.82e-05	0.000136	CcSEcCtD
Fluvoxamine—Pruritus—Furosemide—coronary artery disease	2.81e-05	0.000135	CcSEcCtD
Fluvoxamine—Constipation—Ramipril—coronary artery disease	2.81e-05	0.000135	CcSEcCtD
Fluvoxamine—Nausea—Olmesartan—coronary artery disease	2.8e-05	0.000135	CcSEcCtD
Fluvoxamine—Vomiting—Trandolapril—coronary artery disease	2.8e-05	0.000135	CcSEcCtD
Fluvoxamine—Diarrhoea—Perindopril—coronary artery disease	2.8e-05	0.000135	CcSEcCtD
Fluvoxamine—Decreased appetite—Timolol—coronary artery disease	2.79e-05	0.000135	CcSEcCtD
Fluvoxamine—Vomiting—Enalapril—coronary artery disease	2.79e-05	0.000134	CcSEcCtD
Fluvoxamine—Hypotension—Lisinopril—coronary artery disease	2.79e-05	0.000134	CcSEcCtD
Fluvoxamine—Dizziness—Captopril—coronary artery disease	2.78e-05	0.000134	CcSEcCtD
Fluvoxamine—Rash—Trandolapril—coronary artery disease	2.78e-05	0.000134	CcSEcCtD
Fluvoxamine—Dermatitis—Trandolapril—coronary artery disease	2.78e-05	0.000134	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Timolol—coronary artery disease	2.77e-05	0.000134	CcSEcCtD
Fluvoxamine—Fatigue—Timolol—coronary artery disease	2.77e-05	0.000133	CcSEcCtD
Fluvoxamine—Rash—Enalapril—coronary artery disease	2.77e-05	0.000133	CcSEcCtD
Fluvoxamine—Dermatitis—Enalapril—coronary artery disease	2.76e-05	0.000133	CcSEcCtD
Fluvoxamine—Headache—Trandolapril—coronary artery disease	2.76e-05	0.000133	CcSEcCtD
Fluvoxamine—Vomiting—Telmisartan—coronary artery disease	2.75e-05	0.000133	CcSEcCtD
Fluvoxamine—Asthenia—Losartan—coronary artery disease	2.75e-05	0.000133	CcSEcCtD
Fluvoxamine—Headache—Enalapril—coronary artery disease	2.75e-05	0.000132	CcSEcCtD
Fluvoxamine—Pain—Timolol—coronary artery disease	2.75e-05	0.000132	CcSEcCtD
Fluvoxamine—Nausea—Niacin—coronary artery disease	2.74e-05	0.000132	CcSEcCtD
Fluvoxamine—Rash—Telmisartan—coronary artery disease	2.73e-05	0.000132	CcSEcCtD
Fluvoxamine—Dermatitis—Telmisartan—coronary artery disease	2.73e-05	0.000131	CcSEcCtD
Fluvoxamine—Diarrhoea—Furosemide—coronary artery disease	2.72e-05	0.000131	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.72e-05	0.000131	CcSEcCtD
Fluvoxamine—Pruritus—Losartan—coronary artery disease	2.71e-05	0.000131	CcSEcCtD
Fluvoxamine—Headache—Telmisartan—coronary artery disease	2.71e-05	0.000131	CcSEcCtD
Fluvoxamine—Feeling abnormal—Ramipril—coronary artery disease	2.71e-05	0.000131	CcSEcCtD
Fluvoxamine—Dizziness—Perindopril—coronary artery disease	2.7e-05	0.00013	CcSEcCtD
Fluvoxamine—Insomnia—Lisinopril—coronary artery disease	2.7e-05	0.00013	CcSEcCtD
Fluvoxamine—Nausea—Pravastatin—coronary artery disease	2.7e-05	0.00013	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ramipril—coronary artery disease	2.69e-05	0.00013	CcSEcCtD
Fluvoxamine—Paraesthesia—Lisinopril—coronary artery disease	2.68e-05	0.000129	CcSEcCtD
Fluvoxamine—Vomiting—Captopril—coronary artery disease	2.68e-05	0.000129	CcSEcCtD
Fluvoxamine—Dyspnoea—Lisinopril—coronary artery disease	2.66e-05	0.000128	CcSEcCtD
Fluvoxamine—Rash—Captopril—coronary artery disease	2.65e-05	0.000128	CcSEcCtD
Fluvoxamine—Dermatitis—Captopril—coronary artery disease	2.65e-05	0.000128	CcSEcCtD
Fluvoxamine—Somnolence—Lisinopril—coronary artery disease	2.65e-05	0.000128	CcSEcCtD
Fluvoxamine—Feeling abnormal—Timolol—coronary artery disease	2.65e-05	0.000128	CcSEcCtD
Fluvoxamine—Headache—Captopril—coronary artery disease	2.64e-05	0.000127	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Timolol—coronary artery disease	2.63e-05	0.000127	CcSEcCtD
Fluvoxamine—Dizziness—Furosemide—coronary artery disease	2.63e-05	0.000127	CcSEcCtD
Fluvoxamine—Dyspepsia—Lisinopril—coronary artery disease	2.62e-05	0.000126	CcSEcCtD
Fluvoxamine—Diarrhoea—Losartan—coronary artery disease	2.62e-05	0.000126	CcSEcCtD
Fluvoxamine—Nausea—Trandolapril—coronary artery disease	2.62e-05	0.000126	CcSEcCtD
Fluvoxamine—Urticaria—Ramipril—coronary artery disease	2.61e-05	0.000126	CcSEcCtD
Fluvoxamine—Nausea—Enalapril—coronary artery disease	2.61e-05	0.000126	CcSEcCtD
Fluvoxamine—Vomiting—Perindopril—coronary artery disease	2.6e-05	0.000125	CcSEcCtD
Fluvoxamine—Abdominal pain—Ramipril—coronary artery disease	2.6e-05	0.000125	CcSEcCtD
Fluvoxamine—Body temperature increased—Ramipril—coronary artery disease	2.6e-05	0.000125	CcSEcCtD
Fluvoxamine—Decreased appetite—Lisinopril—coronary artery disease	2.59e-05	0.000125	CcSEcCtD
Fluvoxamine—Rash—Perindopril—coronary artery disease	2.58e-05	0.000124	CcSEcCtD
Fluvoxamine—Dermatitis—Perindopril—coronary artery disease	2.57e-05	0.000124	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.57e-05	0.000124	CcSEcCtD
Fluvoxamine—Nausea—Telmisartan—coronary artery disease	2.57e-05	0.000124	CcSEcCtD
Fluvoxamine—Fatigue—Lisinopril—coronary artery disease	2.57e-05	0.000124	CcSEcCtD
Fluvoxamine—Headache—Perindopril—coronary artery disease	2.56e-05	0.000123	CcSEcCtD
Fluvoxamine—Urticaria—Timolol—coronary artery disease	2.55e-05	0.000123	CcSEcCtD
Fluvoxamine—Pain—Lisinopril—coronary artery disease	2.55e-05	0.000123	CcSEcCtD
Fluvoxamine—Constipation—Lisinopril—coronary artery disease	2.55e-05	0.000123	CcSEcCtD
Fluvoxamine—Abdominal pain—Timolol—coronary artery disease	2.54e-05	0.000122	CcSEcCtD
Fluvoxamine—Body temperature increased—Timolol—coronary artery disease	2.54e-05	0.000122	CcSEcCtD
Fluvoxamine—Dizziness—Losartan—coronary artery disease	2.53e-05	0.000122	CcSEcCtD
Fluvoxamine—Vomiting—Furosemide—coronary artery disease	2.53e-05	0.000122	CcSEcCtD
Fluvoxamine—Rash—Furosemide—coronary artery disease	2.5e-05	0.000121	CcSEcCtD
Fluvoxamine—Dermatitis—Furosemide—coronary artery disease	2.5e-05	0.000121	CcSEcCtD
Fluvoxamine—Nausea—Captopril—coronary artery disease	2.5e-05	0.00012	CcSEcCtD
Fluvoxamine—Headache—Furosemide—coronary artery disease	2.49e-05	0.00012	CcSEcCtD
Fluvoxamine—Feeling abnormal—Lisinopril—coronary artery disease	2.46e-05	0.000118	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Lisinopril—coronary artery disease	2.44e-05	0.000117	CcSEcCtD
Fluvoxamine—Vomiting—Losartan—coronary artery disease	2.44e-05	0.000117	CcSEcCtD
Fluvoxamine—Nausea—Perindopril—coronary artery disease	2.43e-05	0.000117	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ramipril—coronary artery disease	2.42e-05	0.000117	CcSEcCtD
Fluvoxamine—Rash—Losartan—coronary artery disease	2.42e-05	0.000116	CcSEcCtD
Fluvoxamine—Dermatitis—Losartan—coronary artery disease	2.41e-05	0.000116	CcSEcCtD
Fluvoxamine—Headache—Losartan—coronary artery disease	2.4e-05	0.000116	CcSEcCtD
Fluvoxamine—Urticaria—Lisinopril—coronary artery disease	2.37e-05	0.000114	CcSEcCtD
Fluvoxamine—Hypersensitivity—Timolol—coronary artery disease	2.37e-05	0.000114	CcSEcCtD
Fluvoxamine—CYP3A4—blood—coronary artery disease	2.36e-05	0.0129	CbGeAlD
Fluvoxamine—Nausea—Furosemide—coronary artery disease	2.36e-05	0.000114	CcSEcCtD
Fluvoxamine—Asthenia—Ramipril—coronary artery disease	2.36e-05	0.000114	CcSEcCtD
Fluvoxamine—Body temperature increased—Lisinopril—coronary artery disease	2.36e-05	0.000114	CcSEcCtD
Fluvoxamine—Abdominal pain—Lisinopril—coronary artery disease	2.36e-05	0.000114	CcSEcCtD
Fluvoxamine—Pruritus—Ramipril—coronary artery disease	2.33e-05	0.000112	CcSEcCtD
Fluvoxamine—CYP2D6—blood—coronary artery disease	2.32e-05	0.0127	CbGeAlD
Fluvoxamine—Asthenia—Timolol—coronary artery disease	2.31e-05	0.000111	CcSEcCtD
Fluvoxamine—Nausea—Losartan—coronary artery disease	2.28e-05	0.00011	CcSEcCtD
Fluvoxamine—Pruritus—Timolol—coronary artery disease	2.27e-05	0.00011	CcSEcCtD
Fluvoxamine—Diarrhoea—Ramipril—coronary artery disease	2.25e-05	0.000108	CcSEcCtD
Fluvoxamine—ABCB1—heart—coronary artery disease	2.24e-05	0.0122	CbGeAlD
Fluvoxamine—Diarrhoea—Timolol—coronary artery disease	2.2e-05	0.000106	CcSEcCtD
Fluvoxamine—Hypersensitivity—Lisinopril—coronary artery disease	2.2e-05	0.000106	CcSEcCtD
Fluvoxamine—Dizziness—Ramipril—coronary artery disease	2.17e-05	0.000105	CcSEcCtD
Fluvoxamine—Asthenia—Lisinopril—coronary artery disease	2.14e-05	0.000103	CcSEcCtD
Fluvoxamine—Dizziness—Timolol—coronary artery disease	2.12e-05	0.000102	CcSEcCtD
Fluvoxamine—ABCB1—cardiovascular system—coronary artery disease	2.11e-05	0.0115	CbGeAlD
Fluvoxamine—Pruritus—Lisinopril—coronary artery disease	2.11e-05	0.000102	CcSEcCtD
Fluvoxamine—Vomiting—Ramipril—coronary artery disease	2.09e-05	0.000101	CcSEcCtD
Fluvoxamine—Rash—Ramipril—coronary artery disease	2.07e-05	9.99e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Ramipril—coronary artery disease	2.07e-05	9.98e-05	CcSEcCtD
Fluvoxamine—Headache—Ramipril—coronary artery disease	2.06e-05	9.92e-05	CcSEcCtD
Fluvoxamine—Vomiting—Timolol—coronary artery disease	2.04e-05	9.84e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Lisinopril—coronary artery disease	2.04e-05	9.83e-05	CcSEcCtD
Fluvoxamine—Rash—Timolol—coronary artery disease	2.03e-05	9.76e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Timolol—coronary artery disease	2.02e-05	9.75e-05	CcSEcCtD
Fluvoxamine—Headache—Timolol—coronary artery disease	2.01e-05	9.7e-05	CcSEcCtD
Fluvoxamine—Dizziness—Lisinopril—coronary artery disease	1.97e-05	9.5e-05	CcSEcCtD
Fluvoxamine—Nausea—Ramipril—coronary artery disease	1.95e-05	9.41e-05	CcSEcCtD
Fluvoxamine—Nausea—Timolol—coronary artery disease	1.91e-05	9.2e-05	CcSEcCtD
Fluvoxamine—Vomiting—Lisinopril—coronary artery disease	1.9e-05	9.13e-05	CcSEcCtD
Fluvoxamine—Rash—Lisinopril—coronary artery disease	1.88e-05	9.06e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Lisinopril—coronary artery disease	1.88e-05	9.05e-05	CcSEcCtD
Fluvoxamine—Headache—Lisinopril—coronary artery disease	1.87e-05	9e-05	CcSEcCtD
Fluvoxamine—Nausea—Lisinopril—coronary artery disease	1.77e-05	8.53e-05	CcSEcCtD
Fluvoxamine—ABCB1—blood—coronary artery disease	1.67e-05	0.00911	CbGeAlD
Fluvoxamine—CYP2B6—Metabolism—CD36—coronary artery disease	3.26e-06	4.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.25e-06	4.76e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.23e-06	4.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.23e-06	4.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—coronary artery disease	3.23e-06	4.72e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ABCA1—coronary artery disease	3.23e-06	4.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPP2CA—coronary artery disease	3.22e-06	4.71e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPA—coronary artery disease	3.22e-06	4.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GGT1—coronary artery disease	3.2e-06	4.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT1—coronary artery disease	3.2e-06	4.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GCLC—coronary artery disease	3.19e-06	4.67e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CETP—coronary artery disease	3.19e-06	4.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CD36—coronary artery disease	3.19e-06	4.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CD36—coronary artery disease	3.19e-06	4.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—LPL—coronary artery disease	3.17e-06	4.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SDC1—coronary artery disease	3.16e-06	4.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPP2CA—coronary artery disease	3.15e-06	4.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.15e-06	4.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.14e-06	4.59e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GGT1—coronary artery disease	3.12e-06	4.57e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT1—coronary artery disease	3.12e-06	4.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.12e-06	4.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.11e-06	4.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—coronary artery disease	3.09e-06	4.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—coronary artery disease	3.09e-06	4.52e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA5—coronary artery disease	3.08e-06	4.51e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.05e-06	4.46e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—coronary artery disease	3.05e-06	4.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.04e-06	4.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—coronary artery disease	3.03e-06	4.43e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—P4HB—coronary artery disease	3.02e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.02e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.01e-06	4.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CD36—coronary artery disease	3.01e-06	4.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.98e-06	4.36e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.98e-06	4.36e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.98e-06	4.36e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPP2CA—coronary artery disease	2.97e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.97e-06	4.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT1—coronary artery disease	2.94e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT1—coronary artery disease	2.94e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AGT—coronary artery disease	2.94e-06	4.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT1—coronary artery disease	2.92e-06	4.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT1—coronary artery disease	2.92e-06	4.27e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CTGF—coronary artery disease	2.92e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—coronary artery disease	2.91e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.89e-06	4.23e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT2—coronary artery disease	2.89e-06	4.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—coronary artery disease	2.88e-06	4.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AGT—coronary artery disease	2.88e-06	4.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.87e-06	4.2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AGT—coronary artery disease	2.87e-06	4.2e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—coronary artery disease	2.85e-06	4.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.85e-06	4.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOA1—coronary artery disease	2.84e-06	4.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.84e-06	4.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—coronary artery disease	2.82e-06	4.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—coronary artery disease	2.81e-06	4.11e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—coronary artery disease	2.81e-06	4.1e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—VCAN—coronary artery disease	2.8e-06	4.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAT—coronary artery disease	2.8e-06	4.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOA1—coronary artery disease	2.79e-06	4.07e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.78e-06	4.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOA1—coronary artery disease	2.78e-06	4.06e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.78e-06	4.06e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—coronary artery disease	2.77e-06	4.05e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAT—coronary artery disease	2.73e-06	3.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOB—coronary artery disease	2.72e-06	3.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AGT—coronary artery disease	2.71e-06	3.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DCN—coronary artery disease	2.7e-06	3.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.67e-06	3.9e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.66e-06	3.89e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—coronary artery disease	2.66e-06	3.88e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOB—coronary artery disease	2.65e-06	3.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.64e-06	3.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.64e-06	3.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOA1—coronary artery disease	2.63e-06	3.84e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.62e-06	3.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.62e-06	3.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.62e-06	3.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.61e-06	3.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.61e-06	3.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.6e-06	3.8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—LPL—coronary artery disease	2.59e-06	3.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.59e-06	3.78e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—coronary artery disease	2.58e-06	3.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.57e-06	3.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAT—coronary artery disease	2.57e-06	3.76e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LIPC—coronary artery disease	2.56e-06	3.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.56e-06	3.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HBA1—coronary artery disease	2.56e-06	3.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.56e-06	3.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAT—coronary artery disease	2.55e-06	3.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOC3—coronary artery disease	2.54e-06	3.71e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—LPL—coronary artery disease	2.53e-06	3.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—coronary artery disease	2.53e-06	3.7e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LDLR—coronary artery disease	2.52e-06	3.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.51e-06	3.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—coronary artery disease	2.51e-06	3.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOB—coronary artery disease	2.5e-06	3.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.49e-06	3.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.49e-06	3.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT1—coronary artery disease	2.49e-06	3.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT1—coronary artery disease	2.49e-06	3.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOB—coronary artery disease	2.48e-06	3.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—coronary artery disease	2.47e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—coronary artery disease	2.47e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCLC—coronary artery disease	2.47e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CETP—coronary artery disease	2.47e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CD36—coronary artery disease	2.46e-06	3.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—coronary artery disease	2.45e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—coronary artery disease	2.45e-06	3.58e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SDC1—coronary artery disease	2.44e-06	3.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.43e-06	3.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.43e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—coronary artery disease	2.42e-06	3.54e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—coronary artery disease	2.42e-06	3.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.41e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CD36—coronary artery disease	2.4e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LPL—coronary artery disease	2.39e-06	3.49e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.37e-06	3.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LPL—coronary artery disease	2.36e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.33e-06	3.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—coronary artery disease	2.33e-06	3.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—coronary artery disease	2.31e-06	3.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—coronary artery disease	2.31e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.3e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.3e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—coronary artery disease	2.28e-06	3.34e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—coronary artery disease	2.28e-06	3.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CD36—coronary artery disease	2.27e-06	3.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—coronary artery disease	2.25e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.25e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CD36—coronary artery disease	2.25e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.24e-06	3.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.24e-06	3.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.23e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.23e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.22e-06	3.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.22e-06	3.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AGT—coronary artery disease	2.22e-06	3.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.21e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—coronary artery disease	2.21e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—coronary artery disease	2.2e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAT—coronary artery disease	2.18e-06	3.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—coronary artery disease	2.17e-06	3.18e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AGT—coronary artery disease	2.17e-06	3.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—coronary artery disease	2.15e-06	3.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOA1—coronary artery disease	2.15e-06	3.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.15e-06	3.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.13e-06	3.11e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—coronary artery disease	2.12e-06	3.1e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOB—coronary artery disease	2.12e-06	3.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—coronary artery disease	2.11e-06	3.09e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—coronary artery disease	2.11e-06	3.08e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOA1—coronary artery disease	2.1e-06	3.07e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—coronary artery disease	2.08e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.06e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.06e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.05e-06	3e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AGT—coronary artery disease	2.04e-06	2.98e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AGT—coronary artery disease	2.02e-06	2.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LPL—coronary artery disease	2.02e-06	2.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—coronary artery disease	2e-06	2.92e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—coronary artery disease	1.99e-06	2.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.99e-06	2.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—coronary artery disease	1.98e-06	2.9e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.98e-06	2.89e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—coronary artery disease	1.97e-06	2.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.97e-06	2.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOA1—coronary artery disease	1.96e-06	2.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—coronary artery disease	1.93e-06	2.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.93e-06	2.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.92e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.92e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CD36—coronary artery disease	1.92e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.9e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—coronary artery disease	1.89e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.88e-06	2.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—coronary artery disease	1.87e-06	2.73e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—coronary artery disease	1.85e-06	2.7e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—coronary artery disease	1.82e-06	2.67e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—coronary artery disease	1.82e-06	2.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.82e-06	2.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—coronary artery disease	1.74e-06	2.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.73e-06	2.53e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AGT—coronary artery disease	1.73e-06	2.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—coronary artery disease	1.73e-06	2.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—coronary artery disease	1.72e-06	2.51e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.71e-06	2.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.7e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—coronary artery disease	1.7e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—coronary artery disease	1.7e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—coronary artery disease	1.69e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAT—coronary artery disease	1.68e-06	2.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOA1—coronary artery disease	1.67e-06	2.45e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—coronary artery disease	1.66e-06	2.43e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.64e-06	2.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOB—coronary artery disease	1.63e-06	2.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—coronary artery disease	1.63e-06	2.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.6e-06	2.34e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—coronary artery disease	1.59e-06	2.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.59e-06	2.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—coronary artery disease	1.57e-06	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPL—coronary artery disease	1.56e-06	2.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—coronary artery disease	1.55e-06	2.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.52e-06	2.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.5e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.49e-06	2.18e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—coronary artery disease	1.48e-06	2.17e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CD36—coronary artery disease	1.48e-06	2.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—coronary artery disease	1.48e-06	2.16e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.46e-06	2.14e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—coronary artery disease	1.45e-06	2.13e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—coronary artery disease	1.45e-06	2.13e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.4e-06	2.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.37e-06	2e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.36e-06	1.99e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—coronary artery disease	1.34e-06	1.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AGT—coronary artery disease	1.33e-06	1.95e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—coronary artery disease	1.33e-06	1.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—coronary artery disease	1.31e-06	1.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.29e-06	1.89e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—coronary artery disease	1.27e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.21e-06	1.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.19e-06	1.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.19e-06	1.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.16e-06	1.7e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.14e-06	1.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—coronary artery disease	1.12e-06	1.64e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—coronary artery disease	1.12e-06	1.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—coronary artery disease	1.02e-06	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—coronary artery disease	9.91e-07	1.45e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—coronary artery disease	9.79e-07	1.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—coronary artery disease	9.7e-07	1.42e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—coronary artery disease	9.68e-07	1.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	9.16e-07	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—coronary artery disease	9.15e-07	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—coronary artery disease	8.96e-07	1.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—coronary artery disease	8.94e-07	1.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	8.43e-07	1.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	8.36e-07	1.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—coronary artery disease	7.49e-07	1.09e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—coronary artery disease	7.31e-07	1.07e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	7.14e-07	1.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—coronary artery disease	6.89e-07	1.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—coronary artery disease	6.83e-07	9.98e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—coronary artery disease	5.83e-07	8.53e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.51e-07	8.06e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—coronary artery disease	4.5e-07	6.58e-06	CbGpPWpGaD
